Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-((7s)-amino-5-azaspiro(2,4)heptan-5-yl)-8-chloro-6-fluoro-1-((1r,2r)-cis-2-fluoro-1-cyclopropyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic Acid
2. 7-(7-amino-5-azaspiro(2.4)heptan-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Sesquihydrate
3. Du 6859
4. Du 6859a
5. Du-6859
6. Du-6859a
7. Sitafloxacin
1. Sitafloxacin Monohydrate
2. Sitafloxacin
3. 163253-35-8
4. 163253-37-0
5. Sitafloxacin Sesquihydrate
6. Sitafloxacin (monohydrate)
7. 45ip57b62b
8. Du-6859a
9. 3-quinolinecarboxylic Acid, 7-((7s)-7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-((1r,2s)-2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, Hydrate (1:1)
10. 7-[(7s)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic Acid;hydrate
11. Unii-45ip57b62b
12. Spifloxacin Hydrate
13. Schembl1060786
14. Chembl3989504
15. Amsp00022
16. Hy-b0395b
17. Akos005145900
18. Am85615
19. 3-quinolinecarboxylic Acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, Monohydrate, (1r-(1alpha(s*),2alpha))-
20. Cs-0009318
21. J-524203
22. Q27258838
23. 3-quinolinecarboxylic Acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, Monohydrate, (1r-(1.alpha.(s*),2.alpha.))-
24. 3-quinolinecarboxylicacid,7-[(7s)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-1,4-dihydro-4- Oxo-,hydrate (2:3)
25. 3-quinolinecarboxylicacid,7-[(7s)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1r,2s)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-,hydrate(2:3)
Molecular Weight | 427.8 g/mol |
---|---|
Molecular Formula | C19H20ClF2N3O4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Exact Mass | 427.1110401 g/mol |
Monoisotopic Mass | 427.1110401 g/mol |
Topological Polar Surface Area | 87.9 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 761 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01M - Quinolone antibacterials
J01MA - Fluoroquinolones
J01MA21 - Sitafloxacin
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?